Morgan Stanley’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $15K | Sell |
|
|||||
|
2023
Q4 | $35.5K | Buy |
|
|||||
|
2023
Q3 | $17.6K | Sell |
|
|||||
|
2023
Q2 | $16.6K | Buy |
|
|||||
|
2023
Q1 | $5.61K | Buy |
|
|||||
|
2022
Q4 | $3.82K | Sell |
|
|||||
|
2022
Q3 | $1K | Buy |
|
|||||
|
2022
Q2 | $2K | Buy |
|
|||||
|
2022
Q1 | $8K | Sell |
|
|||||
|
2021
Q4 | $11K | Buy |
|
|||||
|
2021
Q3 | $19K | Sell |
|
|||||
|
2021
Q2 | $107K | Buy |
|
|||||
|
2021
Q1 | $4K | Sell |
|
|||||
|
2020
Q4 | $9K | Sell |
|
|||||
|
2020
Q3 | $8K | Sell |
|
|||||
|
2020
Q2 | $25K | Sell |
|
|||||
|
2020
Q1 | $215K | Sell |
|
|||||
|
2019
Q4 | $479K | Buy |
|
|||||
|
2019
Q3 | $472K | Sell |
|
|||||
|
2019
Q2 | $1.89M | Buy |
|
|||||
|
2019
Q1 | $1.06M | Buy |
|
|||||
|
2018
Q4 | $1.12M | Sell |
|
|||||
|
2018
Q3 | $2.44M | Sell |
|
|||||
|
2018
Q2 | $6.32M | Buy |
|
|||||
|
2018
Q1 | $4.99M | Sell |
|
|||||
|
2017
Q4 | $11.2M | Buy |
|
|||||
|
2017
Q3 | $1.85M | Sell |
|
|||||
|
2017
Q2 | $3.05M | Buy |
|
|||||
|
2017
Q1 | $2.58M | Sell |
|
|||||
|
2016
Q4 | $7.06M | Buy |
|
|||||
|
2016
Q3 | $5.72M | Sell |
|
|||||
|
2016
Q2 | $11.3M | Buy |
|
|||||
|
2016
Q1 | $11.5M | Buy |
|
|||||
|
2015
Q4 | $2.09M | Buy |
|
|||||
|
2015
Q3 | $1.01M | Buy |
|
|||||
|
2015
Q2 | $476K | Sell |
|
|||||
|
2015
Q1 | $16.3M | Buy |
|
|||||
|
2014
Q4 | $3M | Sell |
|
|||||
|
2014
Q3 | $4.13M | Sell |
|
|||||
|
2014
Q2 | $8.13M | Buy |
|
|||||
|
2014
Q1 | $2.63M | Sell |
|
|||||
|
2013
Q4 | $9.05M | Buy |
|
|||||
|
2013
Q3 | $3.5M | Buy |
|
|||||
|
2013
Q2 | $2.93M | Buy |
|